Dr. Akbar Khan
Curriculum Vitae
akhan@sanoviawellness.com
Qualifications
| 2019 | FAAO – Fellow of the American Academy of Ozone Therapy |
| 2018 | Certified medical ozone therapy doctor (general ozone therapy, basic ProlozoneTM therapy and advanced ProlozoneTM therapy), certified by the American Academy of Ozone Therapy |
| 2018 | IMD, Integrative Medical Doctor (Board of Integrative Medicine) DHS, Doctor of Humanitarian Service (Board of Integrative Medicine) |
| 1994 | CCFP, Certificant of the College of Family Physicians of Canada (University of Toronto). |
| 1992 | MD, Doctor of Medicine (University of Toronto). |
Ozone Certification
| Oct 2018 | AAOT Advanced Prolozone Therapy Certification, 6 hours |
 |
| Jun 2018 | AAOT Beginning Prolozone Therapy Certification, 7.5 hours |  |
| Jun 2018 | AAOT General Ozone Therapy Certification, 15 hours |  |
| Apr 2018 | OWB Hyperbaric Ozone Therapy Certification, 4 hours |  |
| Apr 2018 | OWB DIV Ozone Therapy Certification, 4 hours |  |
| Apr 2018 | OWB Multidisciplinary Ozone Therapy Certification, 18 hours |  |
Memberships
| Canadian Integrative Medical Association |  |
| World Organization of Natural Medicines |  |
| Board of Integrative Medicine |  |
| American Academy of Ozone Therapy |  |
Work Experience
| 2006 to Present |
Founder and Medical Director, Medicor Cancer Centres Inc, the first private integrated cancer treatment centre of its kind in Canada. |
| 2019 to Present | Founder and Medical Director, Sano Via Wellness, a leading Canadian private integrated wellness centre and physician-led ozone therapy centre. |
| 2023 to Present | Research Physician, Dr. Mitch Total Health, Boca Raton, Florida (cancer, chronic disease and anti-aging research) |
| 2019 to 2023 | Member of Board of Directors of NAVCO Pharma, the first Canadian company to use AI to analyze DNA sequences and methylation patterns to select natural medical therapies for patients with chronic incurable conditions. |
| 2016 to 2022 | Volunteer Medical Advisor, LDN Research Trust, UK, a charitable foundation focused on educating doctors and the public about the benefits of low dose naltrexone. |
| 1995 to 2009 | Surgical Assistant, Scarborough Grace Hospital and Scarborough General Hospital, including orthopedic, general, obstetrical, gynecologic, plastic and vascular surgeries, endoscopic surgery and micro-surgery. |
| 1999 to 2007 | Co-Founder and Co-Director, Palliative Interdisciplinary Network, a registered Canadian charitable corporation providing physician-led pain and symptom management and quality of life enhancing medical care to patients in their homes in Scarborough, Ontario. |
| 1995 to 1999 | Team Physician, UTSC Health and Wellness Center, University of Toronto, Scarborough Campus. |
| 1994 to 1997 | Member, Palliative At Home Care Team at Scarborough General Hospital, a group of physicians dedicated to providing home-based palliative care services in Scarborough, Ontario. |
| 1994 to 1996 | Medical Consultant, Addiction Research Foundation. Responsibilities included: medical supervision of research subjects in remifentanil abuse liability trials, and treatment of patients with addictions to cocaine, alcohol and opiates |
Awards
| 2023 | Humanitarian Health Icon award recipient, World Organization of Natural Medicine, Oct 30, 2023 / 20th Anniversary Conference |
| 2019 | Nominated for the Dr. Rogers Prize for excellence in complementary and alternative medicine |
| 2018 | World Organization of Natural Medicines – Order of Excellence Integrative Medicine Award, Oct 28, 2018 |
| 2018 | LocaExpertsTM Integrative Health Award for contribution of one chapter to the Handbook of Holistic Health, Oct 28, 2018 |
Peer-Reviewed Publications
Other Publications
| Book Chapter in the Handbook for Holistic Health (H3), title: “Cancer Prevention and Treatment”, released Oct 2018 |
| Poster Presentation at Reichart Memorial Metabolic Cancer Conference “Tripping Over the Truth”, Baltimore, MD Nov 2017, Dichloroacetate as a Viable Metabolic Adjuvant Cancer Therapy: Strong in vivo Human Evidence |
| Poster Presentation at OMICS 3rd World Conference on Cancer Science and Therapy, Oct 2013, San Francisco, CA, Can Metabolic Therapy of Breast Cancer Outperform Post-Op Adjuvant Chemo and Hormonal Therapy? In vitro Analysis and Clinical Correlation |
| “The Role of Low Dose Naltrexone in Cancer Treatment”, Feb 16, 2009, LDN Research Trust Newsletter, U.K. |
Invited Journal Article Peer Reviews
| Peer Reviewer for open access journal International Journal of Molecular Sciences, Feb 2024, Manuscript Title: “KEAP1-mutant lung cancers weaken anti-tumor immunity and promote an M2-like macrophage phenotype.” |
| Peer Reviewer for open access journal International Journal of Molecular Sciences, Dec 2023, Manuscript Title: “Mitochondrial Glutathione in Cellular Redox Homeostatsis and Disease Manifestation.” |
| Peer Reviewer for open access journal Osteology, Aug 2023, Manuscript Title: “The effectiveness of low intensity laser therapy along with the sciatic nerve field in chronic lumbar radicular pain: A prospective, randomized, single blind, placebo controlled study.” |
| Peer Reviewer for International Journal of Molecular Sciences, Mar 2023, Manuscript Title: “The use of medical ozone in chronic intervertebral disc degeneration can be an etiological and conservative treatment.” |
| Peer Reviewer for Cancers, Dec 2022, Manuscript Title: “Trend of polyp detection rate by sex and age in asymptomatic average-risk and high-risk individuals undergoing screening colonoscopy, 2012-2019” |
| Peer Reviewer for the International Journal of Molecular Sciences, Oct 2022, Manuscript Title: “Oxaliplatin different effects on mitochondria in primary- and metastatic-derived colorectal cancer cells” |
| Peer Review for the World Journal of Surgical Oncology, Sep 2021, Manuscript Title: “Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature” |
| Peer reviewer for Nutrients, Jan 2018 |
| Peer reviewer for Integrative Cancer Therapies, Jun 2017, Manuscript Title: “The long term survival of a patient with Stage IV renal cell carcinoma following an integrative treatment approach including the intravenous alpha-lipoic acid/low dose naltrexone (ALA/N) protocol” |
| Peer reviewer for Oxidative Medicine and Cellular Longevity, Nov 2016, Manuscript Title: “Synthetic isoliquiritigenin inhibits human tongue squamous carcinoma cells through its antioxidant mechanism” |
| Peer reviewer for Pharmaceutical Nanotechnology, Feb 2016, Manuscript Title: “Development and characterization of pH sensitive liposomes containing Dichloroacetate against breast cancer” |
| Peer reviewer for the World Journal of Surgical Oncology, Oct 2014, Manuscript Title: “Successful tongue cancer surgery under general anesthesia in a 99-year-old patient in Okinawa, Japan: A case report” |
Invited Lectures / Post-Graduate Teaching
| Frontiers 7 Ozone Without Borders International Conference: “Use of Ozone in Cancer Therapy”, Santa Barbara, California, USA, Nov 2-4, 2023 |
| World Organization of Natural Medicine Humanitarian Health Summit: “Natural Solutions to Cardiovascular Disease and Cancer”, Toronto, ON, Oct 29, 2023 |
| Nova Southeastern University College of Pharmacy accredited course: “Cancer Therapies 2023: Therapeutic Applications and Outcomes in Case Studies” in collaboration with Dr. Mitchell Ghen, D.O., Fort Lauderdale, FL, USA, Oct 14-15, 2023 |
| IPT Academy 16th Annual International IPT Conference: “Cancer Survivorship With Non-Toxic Metabolic and Immune Therapy”, Avandaro, Mexico, Feb 17-19, 2023 |
| World Organization of Natural Medicines annual conference: “Powerful Methods to Reverse Aging Naturally”, Web Conference, Oct 29-30, 2022 |
| PCCA International Seminar: “Low Dose Naltrexone is a Viable Cancer Therapy”, Houston, Texas, USA, Oct 27-29, 2022 |
| Makers Compounding Pharmacy Lecture Series: “Low Dose Naltrexone as a Cancer Therapy”, Web Conference, Feb 2022 |
| American Academy of Anti-Aging Medicine (A4M) workshop: “Low Dose Naltrexone: The Promise – The Role of Immune Modulation in Cancer”, Las Vegas, NV, Dec 9, 2021 |
| World Organization of Natural Medicines annual conference: “Unleashing a Paradigm Shift in Cancer Management”, Web Conference, Nov 5-6, 2021 |
| LDN Research Trust Conference 2021: “Endogenous Opiates as Natural Cancer Therapy: Case Reports”, Web Conference, Jun 6, 2021 |
| LDN Research Trust Conference 2021: “Endogenous Opiates Provide a Viable Natural Cancer Therapy”, Web Conference, Jun 5, 2021 |
| National Conference of Traditional Healing: “Non-Toxic Cancer Prevention and Therapy: A Nightmare for ‘Cancer Incorporated?’ ”, Web Conference, May 2020 |
| LDN Research Trust Mini Conference 2020: “LDN for Cancer: Lifesaving Therapy or Oncologists’ Nightmare?”, Nassau, Bahamas, Feb 12, 2020 |
| LDN Research Trust Conference 2019: “LDN vs. Chemotherapy: One ‘Unproven’ Therapy Against Another?”, Portland, OR, Jun 6-8, 2019 |
| American Academy of Ozone Therapy annual conference: “Metabolic Cancer Therapy with DCA, DMSO and O3”, Denver, CO, May 2-4, 2019 |
| Next Generation Nicotine Delivery Conference USA: “The Current State of E-Cigarette Research”, a presentation on the latest research and myths about electronic cigarettes, Miami Beach, FL, May 1, 2019 |
| University of Toronto student’s research group guest lecture on metabolic cancer therapy, U of T Scarborough Campus, Nov 20, 2018 |
| World Organization of Natural Medicines annual conference: “A Non-Toxic Approach to Cancer”, Toronto, ON, Oct 27-28, 2018 |
| International College of Integrative Medicine Conference “An Orthomolecular Approach to Cancer”, lecture: “Is Chemotherapy Overrated? Metabolic Therapy with DCA and DMSO – An Alternative Approach”, The Depot, Minneapolis, MN, Oct 19-21, 2018 |
| Next Generation Nicotine Delivery Conference USA – Panelist with Azim Choudhury, Partner Keller Heckman LLP and Dr. Sydana Rogers-Hollins, Principal Scientist Regulatory Affairs, Altria Client Services (moderated by Karl Houghton, Industry Director, Global Data U.K.), Atlanta, GA, Apr 24-25, 2018 |
| Reichart Memorial Metabolic Cancer Conference “Tripping Over the Truth”, hosted by the Reichart family and the Yu Foundation: “A New Approach to Oncology: Targeting Cancer Metabolism with DCA”, Maritime Conference Center, Baltimore, MD, Nov 2017 |
| LDN Research Trust Conference 2017: “Broad Spectrum Gentler Antineoplastics: Breaking the Cycle of Toxic Therapy”, Portland, OR, Sep 2017 |
| Croquer La Vie 2017 Cancer Forum, hosted by Dr. Marlène Boudreault N.D.: “Cancer Prevention and Gentle Cancer Therapy / La Prévention du Cancer et Thérapie Douce en Cancérologie”, Hotel ALT, Brossard, QC, Apr 2017 |
| H.E.A.L conference, hosted by “Dr. Livett” (Mr. Uchenna Hackett): “The Art of Medicine – A New Approach to Cancer”, Livet Wellness Centre Barataria, Trinidad, Sep 2016 |
| Collaborative Oncology Panel Discussion, hosted by the Canadian College of Naturopathic Medicine, Toronto, ON, Apr 2016 |
| LDN Research Trust Conference 2016: “Low Dose Naltrexone (LDN) for Cancer Treatment”, Orlando, FL, Feb 2016 |
| Croquer La Vie 2016 Cancer Forum hosted by Dr. Marlène Boudreault N.D.: “Innovations in Cancer Care: The Art of Medicine”, Spa Eastman, Eastman, QC, Jan 2016 |
| OMA Conference on Innovations in Medicine: “Off-Label Cancer Therapy: Metformin and Naltrexone”, Mount Sinai Hospital, Toronto, ON, Dec 2015 |
| Ontario Justice Education Network Law Day Symposium: “Physician-Assisted Suicide”, Toronto, ON, Apr 2015 |
| Croquer La Vie 2015 Cancer Forum hosted by Dr. Marlène Boudreault N.D.: “Integrative Cancer Care: Gentle Cancer Therapies LDN and DCA”, Spa Eastman, Eastman, QC, Jan 2015 |
| LDN Research Trust Conference 2014: “Low Dose Naltrexone (LDN) as Cancer Therapy”, Las Vegas, NV, Nov 2014 |
| Food as Medicine Forum hosted by Dr. Marlène Boudreault N.D.: “Gentle Cancer Therapies: LDN and DCA”, Montreal, QC, Oct 2014 |
| Hippocrates Health Institute Metabolic Cancer Therapy Forum: “Metabolic Therapy with DCA”, West Palm Beach, FL, May 2014 |
| Ontario Justice Education Network Law Day Symposium: “Mental Health and the Law”, Toronto, ON, Apr 2014 |
| OncANP Naturopathic Cancer Conference: “Copper Chelation with TM: An Anti-Cancer Strategy”, Phoenix, AZ, Feb 2014 |
| American Academy of Anti-Aging Medicine (A4M) conference, 8 hours post-graduate teaching (including fellowship examination preparation) for the American Board fellowship course (ABAARM) in Integrative Cancer Therapy, Las Vegas, NV, Dec 2013 |
| OncANP Naturopathic Cancer Conference: “DCA: Guidelines for Clinical Use”, Phoenix, AZ, Feb 2013 |
| Ontario Justice Education Network Law Day Symposium: “Mental Health and the Law”, Toronto, ON, Apr 2013 |
| ”Integrative Medicine Town Hall, Canadian College of Naturopathic Medicine, Toronto, ON, Nov 2011 |
| Ontario Justice Education Network Law Day Symposium: “Euthanasia and Assisted Suicide”, Toronto, ON, Apr 2011 |
| Ontario Justice Education Network Law Day Symposium: “Deliberating the Medico-Legal Issues of Private Healthcare in Canada”, Toronto, ON, Apr 2010 |
| Ontario Justice Education Network Law Day Symposium: “Euthanasia and Assisted Suicide”, Toronto, ON, Apr 2009 |
| Ontario Justice Education Network Law Day Symposium: “Euthanasia and Assisted Suicide”, Toronto, ON, Apr 2007 |
| Purdue Pharma: “Challenging Cases in Cancer Pain Management”, Toronto, ON, Nov 2006 |
| Purdue Pharma: “Challenging Cases in Cancer Pain Management”, Toronto, ON, Oct 2006 |
| Yee Hong Centre Palliative Care: “Palliation of Respiratory Symptoms”, Toronto, ON, Feb 2006 |
| The Canadian Lung Association: “Integrated Approach to Respiratory Heath – Palliation of Respiratory Symptoms”, Toronto, ON, Sep 2004 |
| The Scarborough Hospital: “Palliation of Respiratory Symptoms”, Toronto, ON, Apr 2004 |
| The Scarborough Hospital: “Palliation of Cancer Symptoms”, Toronto, ON, Jan 2004 |
| Post-graduate teaching in palliative medicine for family medicine residents at Scarborough General Hospital (2000-2005) |
Computer Experience
| Windows environment and applications |
| DOS environment and applications |
| Database programmer and design, Microsoft Access, Visual Basic for Applications |
| Assembly language programmer for 68000 series CPUs |
| Assembly language programming for PIC microcontrollers |
Significant Achievements
| First in Canada to develop a multitargeted metabolic cancer treatment protocol targeting multiple glycolytic and glutamine pathways simultaneously and demonstrate clinical success with the same protocol (in collaboration with Dr. Mitchell Ghen, USA). |
| Succeeded in commencing a private criminal prosecution against various officials at the College of Physicians and Surgeons of Ontario (court ruling that prima facie evidence existed of CPSO crimes) to defend medical freedom in Ontario and hold the medical regulator accountable for malicious prosecution of physicians. |
| First in Canada to develop a comprehensive Canadian cancer prevention program partnering with naturopathic doctors across Canada, and incorporating SV electronic cigarettes, high dose vitamin D, low dose naltrexone, targeted nutrition and fitness and ultra-early cancer detection using the ONCOblot blood test. |
| First in Canada to administer “SEF” or “side effect free” chemo immunotherapy, with over 80% responses in stage 4 cancers of various types (therapy developed by Dr. Kenneth Matsumura, inventor of the artificial liver, artificial pancreas and wrist-watch heart attack alarm). |
| First in the world to develop a computerized pre-printed order system for “SEF” or “side effect free” chemo immunotherapy, including total skeletal spongiosa volume (TSSV) estimation for chemo antidote dose optimization. |
| First in the world to publish human data for off-label use of dichloroacetate in cancer patients, and largest number of patients treated with dichloroacetate (over 2500). |
| First in the world to demonstrate curative potential of dichloroacetate when used as an adjuvant to chemotherapy or radiotherapy (> 5 year complete remissions of glioblastoma multiforme, metastatic recurrent small cell lung cancer and metastatic renal squamous cell cancer). One case published, one poster presentation. |
| First in the world to publish human data for off-label use of dichloroacetate in cancer patients demonstrating long-term disease control (colon cancer, melanoma). |
| First in the world demonstrate synergism of dichloroacetate and metformin against breast cancer using in vitro chemosensitivity testing, and correlate the response in vivo in humans (poster presentation at OMICS conference). |
| First in Canada to develop a PDA-based portable electronic health record system for cancer patients. |
| First in Canada to offer ChemoFitTM chemosensitivity/chemoresistance testing to cancer patients, using live cell cancer cell death (all causes) assay. |
| Student of Matsubyashi Karate-Do since 2006 under Jardine Sensei of Renseikan Dojo Promoted to rank of Shodan / instructor, Nov 2012 (black belt) Promoted to rank of Nidan, Jul 2014 (black belt, 2nd degree) |
| Assisted members of Scarborough community in becoming annual members of the Scarborough Hospital Corporation, and in overthrowing the hospital Board of Directors for violation of Ontario laws and failure to act in the best interests of the patients / community (a legal precedent for Ontario, 2006). |
Hobbies
| Automotive repair and customization |
| Carpentry and furniture design |
| Computer software design |
| Electronic circuit and printed circuit design and construction |
| Home theatre design and construction, audio and video calibration |
| Metalworking, machining, welding |
Sano Via - Empowering Wellness
CONTACT US TODAY